More than 40 large volume wearable injectors are presently available / under development >>>>

The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting in significant efforts to develop efficient and effective drug-device combinations to deliver large volumes of drugs over a convenient period of time.
To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this link 
The USD 2.7 billion and USD 600 million (by 2030) financial opportunity within the large volume wearable injectors market for the delivery of insulin  and of non-insulin drugs, respectively, has been analyzed across the following segments:
Type of Device
  • Patch Pump / Injectors
  • Infusion Pump / Injectors
Product Usability
  • Disposable
  • Re-usable
Therapeutic Area (for non-insulin drugs)
  • Neurological Disorders
  • Cardiovascular Disorders
  • Oncological Disorders
  • Infectious Disorders

Key geographical regions

  • North America
  • Europe
  • Asia Pacific
The report Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices features the following companies, which we identified to be key players in this domain:

Becton Dickinson

Bespak (subsidiary of Consort Medical)



Eli Lilly

Enable Injections





SOOIL Development


Sensile Medical (acquired by Gerresheimer)

SteadyMed Therapeutics (acquired by United Therapeutics)

Tandem Diabetes Care

Weibel CDS (acquired by SHL Medical)

West Pharmaceutical Services

Table of Contents


1. Preface

2. Executive Summary

3. Introduction

 4. Large Volume Wearable Injectors: Current Market Landscape

 5. Product Competitiveness Analysis 

 6. Large Volume Wearable Injectors: Key Players

 7. Drug Device Combinations: Tabulated Profiles

 8. Partnerships and Collaborations

 9. Key Acquisition Targets

 10. Patent Analysis

 11. Large Volume Wearable Injectors: Likely Drug Candidates
 12. Emerging Trends on Social Media
 13. Clinical Trial Analysis
 14. Case Study: Role of CMOs in Device Development and Manufacturing
 15. Regulatory and Reimbursement Landscape for Medical Devices
 16. Market Sizing and Opportunity Analysis
 17. SWOT Analysis
 18. Executive Insights
 19. Appendix 1: Tabulated Data
 20. Appendix 2: List of Companies and Organizations
 To purchase a copy, please visit

Contact Details


Gaurav Chaudhary


+1 (415) 800 3415

 [email protected] 

You may also like


No comments yet... Be the first to leave a reply! Login here

0 Karma
747 Posts

Made with by Mamby